International Reference Pricing (IRP) is the most common mechanism used by payers around the world to set the price of a drug. The price is derived by benchmarking or referencing prices from a basket of countries. IRP rules are interconnected and a price reduction in one country may impact diverse countries across different regions. Awareness of the impact of IRP across the life-cycle of a medicine is an absolute must for companies.
The IRP Spotlight reports provide customers with the understanding of the inter-connectivity of this pricing method on a per country basis allowing you to make the most informed IRP decision for your products.
This report provides a rounded view of the applicable IRP rules across >100 markets via the following sections:
Global matrix demonstrating how countries are referencing each other, either formally or informally
Individual country tables providing high-level view into the applicable IRP rules at country-level
The IRP Spotlight reports provide customers with the understanding of the inter-connectivity of this pricing method on a per country basis allowing you to make the most informed IRP decision for your products.
This report provides a rounded view of the applicable IRP rules across >100 markets via the following sections:
Global matrix demonstrating how countries are referencing each other, either formally or informally
Individual country tables providing high-level view into the applicable IRP rules at country-level
